In 2025, improving digital marketing is key to building an ophthalmic practice, according to a speaker at Telling It Like It ...
The U.S. maternal mortality crisis is driven by various factors, but primary care providers are uniquely positioned to ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in ...
The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of ...
An AI model demonstrated efficacy at identifying moderate to severe depression through speech patterns, according to a ...
American Indian and Alaska Native communities are some of the most underserved minoritized groups in the United States, and ...
The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
A one-time injection of Lumevoq demonstrated sustained visual acuity improvements with a favorable safety profile at 5 years ...
Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...
Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results